Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gideon Rechavi

Showing results (251-260 of 297) with videos related to

Pageof 30
Sort By:
Plos One|December 11, 2013
Epidermal growth-factor-induced transcript isoform variation drives mammary cell migrationWolfgang J Köstler, Amit Zeisel, Cindy Körner, et al.
Journal of the National Cancer Institute|November 15, 2023
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approachShirly Grynberg, Marilena Vered, Ronnie Shapira-Frommer, et al.
Human Mutation|November 7, 2019
Netrin-G2 dysfunction causes a Rett-like phenotype with areflexiaGali Heimer, Geeske M van Woerden, Ortal Barel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesisItamar Harel, Yoshiro Maezawa, Roi Avraham, et al.
The Journal of Experimental Medicine|June 20, 2007
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and plateletsRonit Pasvolsky, Sara W Feigelson, Sara Sebnem Kilic, et al.
Molecular Cell|May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signalsYaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Plos One|May 20, 2016
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2009
Homozygous SLC2A9 mutations cause severe renal hypouricemiaDganit Dinour, Nicola K Gray, Susan Campbell, et al.
Plos One|August 23, 2016
Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.
Pageof 30

Showing results (251-260 of 297) with videos related to

Sort By:
Pageof 30
Plos One|December 11, 2013
Epidermal growth-factor-induced transcript isoform variation drives mammary cell migrationWolfgang J Köstler, Amit Zeisel, Cindy Körner, et al.
Journal of the National Cancer Institute|November 15, 2023
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approachShirly Grynberg, Marilena Vered, Ronnie Shapira-Frommer, et al.
Human Mutation|November 7, 2019
Netrin-G2 dysfunction causes a Rett-like phenotype with areflexiaGali Heimer, Geeske M van Woerden, Ortal Barel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesisItamar Harel, Yoshiro Maezawa, Roi Avraham, et al.
The Journal of Experimental Medicine|June 20, 2007
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and plateletsRonit Pasvolsky, Sara W Feigelson, Sara Sebnem Kilic, et al.
Molecular Cell|May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signalsYaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Plos One|May 20, 2016
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2009
Homozygous SLC2A9 mutations cause severe renal hypouricemiaDganit Dinour, Nicola K Gray, Susan Campbell, et al.
Plos One|August 23, 2016
Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.
Pageof 30